UK new medical technology access report keeps industry on tenterhooks:
This article was originally published in Clinica
Executive Summary
At the time of going to press today, the House of Commons Health Committee had not yet posted its eagerly-awaited report on "The use of new medical technologies within the NHS". The report, seen by Clinica, is due to be posted on the Committee's website by April 11 at the latest, when the Parliament is dissolved ahead of the general elections of May 5. A full overview and industry response will appear in the next issue of Clinica.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.